Frontline PLC/ CY0200352116 /
| 2024-06-03 3:04:52 PM | Chg. - | Volume | Bid2024-05-27 | Ask2024-05-30 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 294.35NOK | - | 104 Turnover: 30,612.40 |
-Bid Size: - | -Ask Size: - | 63.09 bill.NOK | - | - |
GlobeNewswire
06-06
Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European...
GlobeNewswire
06-04
Irdeto and Velociti Partner to Revolutionize Fleet Management by Building a Keyless Future
GlobeNewswire
06-03
Aptose Announces Closing of $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasd...
GlobeNewswire
06-03
Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival ...
GlobeNewswire
06-03
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatmen...
GlobeNewswire
05-31
Verizon Business brings the Verizon Business Innovation Sessions to New York City
GlobeNewswire
05-31
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
05-31
Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clon...
GlobeNewswire
05-28
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hosp...
GlobeNewswire
05-27
Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible ...
GlobeNewswire
05-24
Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress
GlobeNewswire
05-23
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual M...
GlobeNewswire
05-23
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
05-21
Dalrada Financial Corporation Healthcare Subsidiary, Genefic, Inc., Acquires IV Services Infusion Ph...
